|COPD Research and Innovation|
The Southampton COPD group and Southampton COPD Community Partnerships are actively involved in a number of research areas. We focus on research projects that we believe will make the greatest impact on the lives of our COPD patients.
We currently run studies investigating:
The integration of our clinical and research teams increases our capacity to deliver care to our patients and helps push the boundaries of current knowledge. Patients engage with these research programs because they feel it benefits not only them, but contributes towards medical knowledge to help others with the disease.
1. Innovation in service delivery
By working closely with practices within the city to improve the diagnostic rate through education the prevalence rate increased by 50% during a 12-month period. The second objective was achieved by cohorting the frequent flyer population (>3 admissions per year) and formulating a bespoke intervention package. This intervention reduced our overall admission rate by almost 20%. Details of this project are available on request. We continue to innovate in a number of key areas from pathway delivery and primary care partnerships to acute pulmonary rehabilitation projects. We are a key site in delivering work for the Department Of Health under their Lung Improvement Program.
2. Basic Science Research
The Southampton COPD group is leading the way in investigating the cause of infectious exacerbation sponsored by GSK The aim of this study is to generate epidemiological data to further explore determinants of Chronic Obstructive Pulmonary Disease (COPD) and the contribution of bacterial and viral pathogens to Acute Exacerbation of COPD (AECOPD) episodes. Details can be found here.
3. Phase II-IV Studies
The group also has a strong track record in delivering IMP studies for industry. In the last year we have been the largest UK recruiters to some major global studies in COPD.